GTX INC (84) | Human Resources (22)
Browse by Subcategory
Recent Contracts
-
2019 Incentive Award Plan of the Registrant effective June 7, 2019 (the 2019 Plan)
(Filed With SEC on March 10, 2022)
-
Employment Agreement dated May 17, 2021 between Oncternal Therapeutics, Inc. and Salim Yazji, M.D
(Filed With SEC on August 5, 2021)
-
Employment Transition Agreement between Frank Hsu, M.D. and Registrant, dated February 24, 2021
(Filed With SEC on May 6, 2021)
-
Non-Employee Director Compensation Policy, as amended and restated, effective March 18, 2021
(Filed With SEC on May 6, 2021)
-
Consulting Agreement dated September 20, 2019 between Robert J. Wills. Ph.D. and Oncternal Therapeutics, Inc
(Filed With SEC on March 16, 2020)
-
Employment Agreement dated April 12, 2021 between Oncternal Therapeutics, Inc. and Chase Leavitt
(Filed With SEC on August 5, 2021)
-
Amended and Restated Employment Agreement dated January 6, 2021 between Oncternal Therapeutics, Inc. and Raj Krishnan, Ph.D
(Filed With SEC on August 5, 2021)
-
Amendment No. 1 to the Oncternal Therapeutics, Inc. 2021 Employment Inducement Incentive Award Plan
(Filed With SEC on May 28, 2021)
-
Oncternal Therapeutics, Inc. 2021 Employment Inducement Incentive Award Plan and form of stock option agreement thereunder
(Filed With SEC on February 17, 2021)
-
Amended Oncternal Therapeutics, Inc. Annual Incentive Plan
(Filed With SEC on November 8, 2019)
-
Employment Agreement dated September 5, 2019 between Oncternal Therapeutics, Inc. and Hazel M. Aker
(Filed With SEC on November 8, 2019)
-
Employment Agreement dated September 5, 2019 between Oncternal Therapeutics, Inc. and Richard G. Vincent
(Filed With SEC on November 8, 2019)
-
Employment Agreement dated September 12, 2019 between Oncternal Therapeutics, Inc. and James B. Breitmeyer, M.D
(Filed With SEC on November 8, 2019)
-
Employment Agreement dated September 9, 2019 between Oncternal Therapeutics, Inc. and Igor P. Bilinsky, Ph.D
(Filed With SEC on November 8, 2019)
-
Employment Agreement dated September 5, 2019 between Oncternal Therapeutics, Inc. and Gunnar F. Kaufmann, Ph.D
(Filed With SEC on November 8, 2019)
-
Employment Agreement dated August 26, 2019 between Oncternal Therapeutics, Inc. and Frank Hsu, M.D
(Filed With SEC on November 8, 2019)
-
Form of Stock Option Agreement under the Oncternal Therapeutics, Inc. 2015 Equity Incentive Plan, as amended
(Filed With SEC on April 8, 2019)
-
Consulting Agreement dated April 3, 2017, between Oncternal Therapeutics, Inc. and Richard G. Vincent
(Filed With SEC on April 8, 2019)
-
Employment Letter dated January 1, 2019, between Oncternal Therapeutics, Inc. and Richard G. Vincent
(Filed With SEC on April 8, 2019)
-
Employment Letter dated May 31, 2017, between Oncternal Therapeutics, Inc. and James B. Breitmeyer, M.D., Ph.D
(Filed With SEC on April 8, 2019)
-
Form of Early Exercise Stock Option Agreement under the Oncternal Therapeutics, Inc. 2015 Equity Incentive Plan, as amended
(Filed With SEC on April 8, 2019)
-
Oncternal Therapeutics, Inc. 2015 Equity Incentive Plan, as amended
(Filed With SEC on April 8, 2019)